Last reviewed · How we verify
NCT07433218: FRESH
Frequency of Electrical Acupoint Stimulation on Hypotension During Induction
NA trial testing electrical acupoint stimulation in Anesthesia in 84 participants. Not yet recruiting.
1 August 2026
Quick facts
| Lead sponsor | Zhihong LU |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 84 |
| Start date | 1 March 2026 |
| Primary completion | 1 August 2026 |
| Estimated completion | 1 November 2026 |
Drugs / interventions tested
- electrical acupoint stimulation
- electrodes pasted
- high-frequency electrical stimulation
- low-frequency electrical stimulation
Conditions studied
- Anesthesia — all drugs for Anesthesia →
- Hypotension — all drugs for Hypotension →
Sponsor
Zhihong LU — full company profile →
Who can join
65 and older, any sex, with Anesthesia or Hypotension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Within 30 minutes before anesthesia, acupoint electrical stimulation at different frequencies were applied at Neiguan and Jian Shi. The changes in blood pressure during the anesthesia induction period were compared between the high-frequency group and the low-frequency group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07433218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of electrical acupoint stimulation
Trials testing the same drug.
- NCT07365345 — Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients · NA · recruiting
Other recruiting trials for Anesthesia
Currently open trials in the same condition.
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
- NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting
Other Zhihong LU trials
Trials by the same sponsor.
- NCT07440121 — Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection · NA · not yet recruiting
- NCT07445399 — Drawing Therapy for pReoperative Anxiety in Waiting (DRAW) · NA · not yet recruiting
- NCT06521632 — Acupoint Stimulation Improves Cognition Under Hypoxia · NA · not yet recruiting
- NCT06161662 — STimulation Electronically of Acupoints for Postoperative Delirium in elderlY Patients · NA · completed
- NCT06170918 — Dose of Remimazolam in Children for Intubation · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07433218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhihong LU
- Last refreshed: 25 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07433218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing